The Global Angelman Syndrome Registry
NCT05293184 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2024-02-23
Summary
The Global Angelman Syndrome Registry is an online patient organisation driven registry to collect information about the natural history of children and adults with Angelman Syndrome. The registry will facilitate 1) recruitment for clinical trials into therapies and interventions to benefit participants with Angelman Syndrome and their families, and 2) advancement of research and best standards of care for Angelman Syndrome.
The registry is currently available in English, Spanish, Traditional Chinese, Italian, Polish, Hindi, and Brazilian Portuguese.
Conditions
Interventions
- OTHER
-
Observational study only
Sponsors & Collaborators
-
Queensland University of Technology
collaborator OTHER -
Foundation for Angelman Syndrome Therapeutics, Australia
lead OTHER
Principal Investigators
-
Helen (Honey) Heussler, MBBS, FRACP DM · The University of Queensland
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-28
- Primary Completion
- 2099-12-31
- Completion
- 2099-12-31
Countries
- Australia
Study Locations
More Related Trials
-
Long-term Extension of GTX-102 in Angelman Syndrome
NCT06415344 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome
NCT03882918 ·Status: TERMINATED ·Phase: PHASE3
-
Angelman Natural History Study - FAST Spain
NCT06115109 ·Status: RECRUITING
-
An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome
NCT05011851 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of OV101 in Individuals With Angelman Syndrome (AS)
NCT04106557 ·Status: COMPLETED ·Phase: PHASE3
-
Natural History of Rett Syndrome & Related Disorders
NCT02738281 ·Status: COMPLETED
-
A Study in Adults and Adolescents With Angelman Syndrome (STARS)
NCT02996305 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS)
NCT04428281 ·Status: COMPLETED ·Phase: PHASE1
-
Pompe Disease Registry Protocol
NCT00231400 ·Status: RECRUITING
-
A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome
NCT07181837 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
REVEAL: A Phase 3 Study of ION582 in Angelman Syndrome
NCT06914609 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical and Biological Characterization of Patients and Collection of Samples
NCT04499040 ·Status: UNKNOWN ·Phase: NA
-
A Study to Investigate the Pharmacokinetics (PK) and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype.
NCT05630066 ·Status: COMPLETED ·Phase: PHASE2
-
The International Registry for Leigh Syndrome
NCT03137355 ·Status: RECRUITING
-
Gaucherite - A Study to Stratify Gaucher Disease
NCT03240653 ·Status: RECRUITING
-
Natural History Study of Participants With Sanfilippo Syndrome Type IIIC
NCT05825131 ·Status: RECRUITING
-
The Natural History Study of Patients With Sanfilippo Disease(s) (MPS3)
NCT05705674 ·Status: RECRUITING
-
Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
NCT06999954 ·Status: RECRUITING
-
Krabbe Disease Global Patient Registry
NCT02993796 ·Status: RECRUITING
-
Natural History of Netherton Syndrome
NCT05902663 ·Status: TERMINATED
-
STXBP1 and SYNGAP1 Related Disorders Natural History Study
NCT06555965 ·Status: RECRUITING
-
National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
NCT05563831 ·Status: COMPLETED
-
GM1 and GM2 Gangliosidosis PROspective Neurological Disease TrajectOry Study (PRONTO)
NCT05109793 ·Status: COMPLETED
-
Fabry Disease Registry & Pregnancy Sub-registry
NCT00196742 ·Status: RECRUITING
-
Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection
NCT06377462 ·Status: RECRUITING